However, by supporting your metabolism, energy levels, and focus, they can certainly aid in a holistic weight management strategy
MASLD Substudy Sanyal et al., Nature Medicine (2024) Sanyal and colleagues conducted a prespecified phase 2a substudy of the original phase 2 obesity trial, evaluating retatrutide in participants with metabolic dysfunction-associated steatotic liver disease (MASLD)
A high-protein breakfast or lunch can keep GLP-1 levels elevated throughout the afternoon, reducing afternoon snacking and energy crashes
Slimpic is not presented as a rapid transformation tool
The site even names drops a Stanford University doctor endorsing it
More research directly comparing GLP-1 medications to comprehensive lifestyle interventions (diet, exercise, and behavioral therapy) is needed